Thomas Daniel

Thomas Daniel

Director/Board Member at GOSSAMER BIO, INC.

Net worth: 8 800 $ as of 31/05/2026

72 year
Health Technology
Consumer Services
Commercial Services

Profile

Thomas O.
Daniel
is currently Chairman-Overseers Board at The Scripps Research Institute; Chairman at Locanabio, Inc., Life Science Cares San Diego LLC, Gate Therapeutics, and Trotana, Inc.; Director at FerruMax Pharmaceuticals, Inc. and Lupus Research Alliance, Inc.; Independent Director at Gossamer Bio, Inc.; Director at Aspen Neuroscience, Inc. and Mozart Therapeutics, Inc.; and Trustee at The Reed Institute.
Former roles include Chairman-Research Division at Celgene Corp., Independent Director at Zafgen, Inc., Director at Abide Therapeutics, Inc., PharmAkea, Inc., Alliance for Lupus Research, Pharmaceutical Research & Manufacturers of America, Epizyme, Inc., ImmusanT, Inc., Magenta Therapeutics, Inc., Vir Biotechnology, Inc., Vanderbilt Vascular Biology Center, Sana Biotechnology, Inc., Vividion Therapeutics, Inc., and Larimar Therapeutics, Inc.; Chief Scientific Officer & Director at Ambrx, Inc.; Independent Director at Juno Therapeutics, Inc.; Executive Director at Catalyst Advisors LP; Vice President-Research at Amgen, Inc.; Senior Vice President-Discovery Research at Immunex Corp.; Venture Partner at ARCH Venture Partners LLC; and Professor at Vanderbilt University.
Education includes an undergraduate degree from Southern Methodist University (1974) and doctorates from The University of Texas at Austin and The University of Texas Southwestern Medical Center (both 1978).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2026 38,095 ( 0.01% ) 8 800 $ 31/05/2026

Thomas Daniel active positions

CompaniesPositionStart
GOSSAMER BIO, INC. Director/Board Member 01/01/2018
Director/Board Member -
Director/Board Member 01/02/2020
Director/Board Member 01/06/2020
Chairman -
Director/Board Member 01/03/2017
Chairman -
Corporate Officer/Principal -
Director/Board Member -

Former positions of Thomas Daniel

CompaniesPositionEnd
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Thomas Daniel's experience

Training of Thomas Daniel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

86

1st degree connections

34

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies34

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Services

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!